Supplemental Annuity Collective Trust (SACT) of New Jersey’s Ligand Pharmaceuticals LGND Stock Holding History

Supplemental Annuity Collective Trust (SACT) of New Jersey’s Portfolio LGND Stock Details LGND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,290	Closed	-$244K	–	334
2025 Q4	$244K	Sell	1,290 -610	-32%	-$117K	0.06%	199
2025 Q3	$337K	Hold	1,900	–	–	0.09%	185
2025 Q2	$216K	Buy	+1,900	New	+$203K	0.06%	196
2025 Q1	–	Sell	-1,900	Closed	-$204K	–	212
2024 Q4	$204K	Buy	+1,900	New	+$215K	0.06%	206
2022 Q2	–	Sell	-3,046	Closed	-$214K	–	223
2022 Q1	$214K	Hold	3,046	–	–	0.07%	216
2021 Q4	$293K	Hold	3,046	–	–	0.09%	205
2021 Q3	$265K	Hold	3,046	–	–	0.09%	203
2021 Q2	$249K	Hold	3,046	–	–	0.08%	206
2021 Q1	$290K	Buy	+3,046	New	+$288K	0.1%	202
2020 Q3	–	Sell	-3,046	Closed	-$213K	–	217
2020 Q2	$213K	Sell	3,046 -3,206	-51%	-$203K	0.1%	197
2020 Q1	$284K	Hold	6,252	–	–	0.16%	167
2019 Q4	$407K	Hold	6,252	–	–	0.17%	175
2019 Q3	$388K	Sell	6,252 -1,763	-22%	-$111K	0.18%	177
2019 Q2	$571K	Hold	8,015	–	–	0.25%	133
2019 Q1	$629K	Buy	+8,015	New	+$607K	0.28%	121

Other funds holding LGND

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return

Supplemental Annuity Collective Trust (SACT) of New Jersey's LGND Position: Q1 2026 in Review

Supplemental Annuity Collective Trust (SACT) of New Jersey sold out of Ligand Pharmaceuticals (LGND) in Q1 2026, closing a stake of 1,290 shares — an estimated $244K sold.

Supplemental Annuity Collective Trust (SACT) of New Jersey first reported a position in LGND in Q1 2019 and held it in 15 quarters. The position peaked at $629K in Q1 2019. 358 funds tracked by Wall St. Rank hold LGND as of Q1 2026.

Supplemental Annuity Collective Trust (SACT) of New Jersey reported no remaining Ligand Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
Supplemental Annuity Collective Trust (SACT) of New Jersey sold 1,290 Ligand Pharmaceuticals shares in Q1 2026, an estimated $244K.
Supplemental Annuity Collective Trust (SACT) of New Jersey first reported a position in Ligand Pharmaceuticals in Q1 2019 and held it in 15 quarters.
Supplemental Annuity Collective Trust (SACT) of New Jersey's Ligand Pharmaceuticals position peaked at $629K in Q1 2019.
358 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q1 2026.

Based on Supplemental Annuity Collective Trust (SACT) of New Jersey's 13F filing for Q1 2026, filed 1 May 2026.